These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 18155364)

  • 1. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
    Clausen T; Anchersen K; Waal H
    Drug Alcohol Depend; 2008 Apr; 94(1-3):151-7. PubMed ID: 18155364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality among opiate users: opioid maintenance therapy, age and causes of death.
    Clausen T; Waal H; Thoresen M; Gossop M
    Addiction; 2009 Aug; 104(8):1356-62. PubMed ID: 19426288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
    Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing overdose mortality associated with methadone and buprenorphine treatment.
    Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
    Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
    Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
    Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
    Bukten A; Skurtveit S; Gossop M; Waal H; Stangeland P; Havnes I; Clausen T
    Addiction; 2012 Feb; 107(2):393-9. PubMed ID: 21883606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J; Trinh L; Butler B; Randall D; Rubin G
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
    Gibson AE; Degenhardt LJ
    Drug Alcohol Rev; 2007 Jul; 26(4):405-10. PubMed ID: 17564876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study.
    Havnes I; Bukten A; Gossop M; Waal H; Stangeland P; Clausen T
    Drug Alcohol Depend; 2012 Aug; 124(3):307-10. PubMed ID: 22382045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.